INHIBITORS OF JMJD2C AS ANTICANCER AGENTS

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP15786844.9

公开号：

EP3137079A1

申请日:

2015.04.21

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present disclosure provides compounds, pharmaceutical compositions and related methods for the treatment of cancer, e.g., castration-resistant prostate cancer (CRPC). Specifically, the present disclosure provides a series of 8-hydroxyquinoline derivatives which show cytotoxic effects on androgen-independent prostate cancer cells.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/